U.S. funding to now cover study of Novavax's COVID-19 shot in adolescents – Reuters

February 9, 2022

Vials with a sticker reading, "COVID-19 / Coronavirus vaccine / Injection only" and a medical syringe are seen in front of a displayed Novavax logo in this illustration taken October 31, 2020. REUTERS/Dado Ruvic/Illustration
Feb 7 (Reuters) – Novavax Inc (NVAX.O) said on Monday U.S. government funding for its COVID-19 vaccine had been expanded to cover a late-stage study in adolescents with a booster component.
Novavax in July 2020 had received $1.6 billion in funding to develop its protein-based vaccine under a government program aimed at accelerating access to coronavirus vaccines and treatments, formerly called Operation Warp Speed.
The company late last month filed for emergency use authorization of the vaccine for U.S. adults, a long-awaited step following months of struggles with development and manufacturing problems.
Novavax's two-dose shot has received authorizations from the European Union and the World Health Organization and was recently cleared for use in adults in Britain and New Zealand.
Novavax last year started testing its vaccine in adolescents aged 12 to 17.
Currently, rival Pfizer (PFE.N) and its partner BioNTech's COVID-19 vaccine is the only one cleared for individuals in that age group in the United States. The U.S. Food and Drug Administration in January also authorized a booster shot of the companies' vaccine for those 12 years and older.
Novavax in December said receiving an additional booster dose of its vaccine further increased people's immune response to Omicron. The company cited data from ongoing studies of its vaccine's effectiveness in adolescents and as a booster. read more
Our Standards: The Thomson Reuters Trust Principles.
Keep up with the latest medical breakthroughs, healthcare trends, pharmaceutical news and more.
Subscribe to our daily curated newsletter to receive the latest exclusive Reuters coverage delivered to your inbox.
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial, national and international news to professionals via desktop terminals, the world's media organizations, industry events and directly to consumers.
Build the strongest argument relying on authoritative content, attorney-editor expertise, and industry defining technology.
The most comprehensive solution to manage all your complex and ever-expanding tax and compliance needs.
The industry leader for online information for tax, accounting and finance professionals.
Access unmatched financial data, news and content in a highly-customised workflow experience on desktop, web and mobile.
Browse an unrivalled portfolio of real-time and historical market data and insights from worldwide sources and experts.
Screen for heightened risk individual and entities globally to help uncover hidden risks in business relationships and human networks.
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2022 Reuters. All rights reserved


Article Categories:

Leave a Reply

Your email address will not be published.